Board of the College of Pharmacists of British Columbia Regulation

B.C. Reg. 1/2020: Amendments to the Drug Schedules Regulation

Made under the Pharmacy Operations and Drug Scheduling Act

How does this rule affect your organization? One Click reads it against your profile and tells you, on Canada Federal Legislative Tracking. See plans →

Get alerted when the next rule lands

New rules land on their own schedule. Pick how you want to hear about them — we email you when one appears.

Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.

The rule, in full

296 words as published, January 28, 2020. View the original →

B.C. Reg. 1/2020, deposited January 6, 2020, under the PHARMACY OPERATIONS AND DRUG SCHEDULING ACT [section 22 (1)]. Resolution of the Board of the College of Pharmacists of British Columbia, dated October 30, 2019. RESOLVED THAT, in accordance with the authority established in section 22 (1) of the Pharmacy Operations and Drug Scheduling Act, and subject to filing with the Minister as required by section 22 (2) of the Pharmacy Operations and Drug Scheduling Act, the board amend the Drug Schedules Regulation, B.C. Reg. 9/98, to move certain codeine preparations from Schedule 1 to Schedule 1A as outlined in the schedule attached to this resolution. — B. NAKAGAWA, Registrar.

Appendix

1 The Drug Schedules Regulation, B.C. Reg. 9/98, is amended in the Schedules (a) by striking out the following: 1 Codeine, except (a) when prescribed as a single entity, (b) when included in a preparation containing 60 mg or more per dosage unit, or (c) in preparations exempted from the Regulations to the Controlled Drugs and Substances Act (Canada) 1A Codeine when prescribed as a single entity or when included in a preparation containing 60 mg or more per dosage unit , and (b) by adding the following: 1 Codeine and its salts, except (a) when prescribed as a single entity, (b) when included in a preparation containing 60 mg or more per dosage unit, (c) when included in a liquid preparation containing 1.6 mg or more per mL, or (d) in preparations exempted from the Regulations to the Controlled Drugs and Substances Act (Canada) 1A Codeine and its salts when (a) prescribed as a single entity, (b) included in a preparation containing 60 mg or more per dosage unit, or (c) included in a liquid preparation containing 1.6 mg or more per mL .